AI drug discovery startup Latch expands MTS team across chemistry and clinical science

kenbwork · x · 2026-11-17

Latch, an AI drug discovery company, is rapidly expanding its MTS team with open roles in chemistry, medicinal chemistry, molecular design, assay development, translational science, and clinical development/operations/data/trial design, citing impact from projects like GDPx biology, Fireworks SII, and Gemini 4 Hydrogen.

Related event: AI Drug Firm Latch Launches Major Hiring Spree(2 posts)→

Original post →

More from Companies & People

Companies & People channel →